Dai-ichi Life Holdings ( ($JP:8750) ) has issued an update. Dai-ichi Life Holdings announced that it will change its trade ...
Immune checkpoint blockers (ICBs) have revolutionized the treatment of non–small cell lung cancer (NSCLC). Currently, one-dose-fits-all maximalist regimens have been considered the standard of care, ...